Sfoglia per RIVISTA
EUROPEAN JOURNAL OF NEUROLOGY
Collezione ASL Asti

  

Items : 5

Maintenance of response and predictive factors of 1-year GalcanezumAb treatment in real-life migraine patients in Italy: The multicenter prospective cohort GARLIT study in European Journal of Neurology

2023
ASL Asti

Vernieri F; Brunelli N; Marcosano M; Aurilia C; Egeo G; Lovati C; Favoni V; Perrotta A; Maestrini I; Rao R; d'Onofrio L; Finocchi C; Aguggia M; Bono F; Ranieri A; Albanese M; Di Piero V; Cevoli S; Altamura C; Barbanti P; Costa CM; Fofi L; Di Cola FS; d’Onofrio F; Bertuzzo D; Bombardieri F; Messina R; Colombo B; Filippi M; et alii...

Efficacy of rituximab in anti-myelin-associated glycoprotein demyelinating polyneuropathy: Clinical, hematological and neurophysiological correlations during 2?years of follow-up. in European journal of neurology / Eur J Neurol. 2022 Dec;29(12):3611-3622. doi: 10.1111/ene.15553. Epub 2022 Sep 25.

2022
ASL Asti
ASL Città di Torino
AOU Città della Salute di Torino

Lopiano L; Ferrero B; Ferrero S; Drandi D; Artusi CA; Bondielli G; Ferrante M; Di Liberto A; Ragaini S; Cavallo F; Schiavetti I; Cavallo R; Benevolo G; Orsucci L; Dogliotti I; Clerico M; Parisi M; Bertuzzo D;

Late response to anti-CGRP (calcitonin gene-related peptide) monoclonal antibodies: implication for clinical practice in European Journal of Neurology

2022
ASL Asti

Aurilia C; Egeo G; Fiorentini G; Cevoli S; Messina R; Salerno A; Torelli P; Albanese M; Carnevale A; Bono F; D'Amico D; Altamura C; Colombo B; Frediani F; Mercuri B; D'Onofrio F; Grazzi L; Aguggia M; Finocchi C; Di Fiore P; Zucco M; Trimboli M; Bonassi S; Vernieri F; Barbanti P;

Predictors of response to antiCGRP monoclonal antibodies: a multicenter, 24-week, cohort study on 864 migraine patients in European Journal of Neurology

2022
ASL Asti
ASL Vercelli

Egeo G; Aurilia C; Cevoli S; Fiorentini G; Altamura C; Finocchi C; Di Clemente L; Zucco M; Raniero A; Trimboli M; Bono F; Filippi M; Proietti S; Bonassi S; Le Pera D; Albanese M; Grazzi L; Di Fiore P; D'Onofrio F; Aguggia M; Colombo B; Torelli P; Vernieri F; Barbanti P;

Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3-month observational, longitudinal, cohort, multicenter, Italian real-life study in European Journal of Neurology

2022
ASL Asti

Vernieri F; Altamura C; Brunelli N; Costa CM; Aurilia C; Egeo G; Fofi L; Favoni V; Lovati C; Bertuzzo D; d’Onofrio F; Doretti A; Di Fiore P; Finocchi C; Schiano Di Cola F; Ranieri A; Colombo B; Bono F; Albanese M; Cevoli S; Barbanti P; Pierangeli G; Capogrosso C; Aguggia M; Spitaleri D; Messina S; Trogu F; Frediani F; Baldi O; et alii...